171 related articles for article (PubMed ID: 23408226)
1. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival.
Hu CY; Xing Y; Cormier JN; Chang GJ
Cancer; 2013 May; 119(10):1900-7. PubMed ID: 23408226
[TBL] [Abstract][Full Text] [Related]
2. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK
Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764
[TBL] [Abstract][Full Text] [Related]
3. Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer.
Pruitt SL; Gerber DE; Zhu H; Heitjan DF; Maddineni B; Xiong D; Singal AG; Tavakkoli A; Halm EA; Murphy CC
Cancer Med; 2021 Jul; 10(14):4752-4767. PubMed ID: 34190429
[TBL] [Abstract][Full Text] [Related]
4. Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.
Cho H; Mariotto AB; Mann BS; Klabunde CN; Feuer EJ
Am J Epidemiol; 2013 Aug; 178(3):339-49. PubMed ID: 23825168
[TBL] [Abstract][Full Text] [Related]
5. Mortality rates by stage-at-diagnosis.
Clinton K
Semin Surg Oncol; 1994; 10(1):7-11. PubMed ID: 8115787
[TBL] [Abstract][Full Text] [Related]
6. On the estimation of survival.
Henson DE; Ries LA
Semin Surg Oncol; 1994; 10(1):2-6. PubMed ID: 8115782
[TBL] [Abstract][Full Text] [Related]
7. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924
[TBL] [Abstract][Full Text] [Related]
8. Noncancer deaths in white adult cancer patients.
Brown BW; Brauner C; Minnotte MC
J Natl Cancer Inst; 1993 Jun; 85(12):979-87. PubMed ID: 8496983
[TBL] [Abstract][Full Text] [Related]
9. Mortality in Incident Maintenance Dialysis Patients Versus Incident Solid Organ Cancer Patients: A Population-Based Cohort.
Naylor KL; Kim SJ; McArthur E; Garg AX; McCallum MK; Knoll GA
Am J Kidney Dis; 2019 Jun; 73(6):765-776. PubMed ID: 30738630
[TBL] [Abstract][Full Text] [Related]
10. Regional variation in spending and survival for older adults with advanced cancer.
Brooks GA; Li L; Sharma DB; Weeks JC; Hassett MJ; Yabroff KR; Schrag D
J Natl Cancer Inst; 2013 May; 105(9):634-42. PubMed ID: 23482657
[TBL] [Abstract][Full Text] [Related]
11. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study.
Solomon BM; Rabe KG; Slager SL; Brewer JD; Cerhan JR; Shanafelt TD
J Clin Oncol; 2013 Mar; 31(7):930-7. PubMed ID: 23341508
[TBL] [Abstract][Full Text] [Related]
12. Estimating breast cancer-specific and other-cause mortality in clinical trial and population-based cancer registry cohorts.
Dignam JJ; Huang L; Ries L; Reichman M; Mariotto A; Feuer E
Cancer; 2009 Nov; 115(22):5272-83. PubMed ID: 19670456
[TBL] [Abstract][Full Text] [Related]
13. Stage at diagnosis and early mortality from cancer in England.
McPhail S; Johnson S; Greenberg D; Peake M; Rous B
Br J Cancer; 2015 Mar; 112 Suppl 1(Suppl 1):S108-15. PubMed ID: 25734389
[TBL] [Abstract][Full Text] [Related]
14. The impact of state-specific life tables on relative survival.
Stroup AM; Cho H; Scoppa SM; Weir HK; Mariotto AB
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):218-27. PubMed ID: 25417235
[TBL] [Abstract][Full Text] [Related]
15. Expected years of life lost for six potentially preventable cancers in the United States.
Liu PH; Wang JD; Keating NL
Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
[TBL] [Abstract][Full Text] [Related]
16. Evaluating factors associated with unknown SEER Summary Stage 2000 derived from collaborative stage at central registry level.
Hsieh MC; Yu Q; Wu XC; Wohler B; Fan Y; Qiao B; Jemal A; Ajani UA
J Registry Manag; 2012; 39(3):101-6. PubMed ID: 23443453
[TBL] [Abstract][Full Text] [Related]
17. Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death.
Howlader N; Mariotto AB; Woloshin S; Schwartz LM
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):255-64. PubMed ID: 25417239
[TBL] [Abstract][Full Text] [Related]
18. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.
Malmgren JA; Calip GS; Atwood MK; Mayer M; Kaplan HG
Cancer; 2020 Jan; 126(2):390-399. PubMed ID: 31639221
[TBL] [Abstract][Full Text] [Related]
19. Cancer-specific mortality of Asian Americans diagnosed with cancer: a nationwide population-based assessment.
Trinh QD; Nguyen PL; Leow JJ; Dalela D; Chao GF; Mahal BA; Nayak M; Schmid M; Choueiri TK; Aizer AA
J Natl Cancer Inst; 2015 Jun; 107(6):djv054. PubMed ID: 25794888
[TBL] [Abstract][Full Text] [Related]
20. Crude probability of death for cancer patients by spread of disease in New South Wales, Australia 1985 to 2014.
Yu XQ; Dasgupta P; Kahn C; Kou K; Cramb S; Baade P
Cancer Med; 2021 Jun; 10(11):3524-3532. PubMed ID: 33960140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]